Observation of Respiration Following Regional Anaesthesia With Intrathecal Opioids for Caesarean Section
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00544947|
Recruitment Status : Completed
First Posted : October 16, 2007
Last Update Posted : February 4, 2009
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||90 participants|
|Official Title:||Observation of Respiration Following Regional Anaesthesia With Intrathecal Opioids: a Comparison Between Diamorphine and Fentanyl Combined With Postoperative Morphine PCA Using a Carbon Dioxide Tension and Pulse Oximetry Sensor (TOSCA)|
|Study Start Date :||October 2007|
|Actual Primary Completion Date :||July 2008|
|Actual Study Completion Date :||July 2008|
Group D will be patients at Princess Royal Maternity Hospital in Glasgow, where supplementation with intrathecal diamorphine 300mcg is the current anaesthetic technique of choice.
Group F will be patients at the Queen Mother's Maternity Hospital in Glasgow, where supplementation with intrathecal fentanyl 15mcg plus post-operative morphine PCA is the current anaesthetic technique of choice for elective caesarean section.
- transcutaneous carbon dioxide tension [ Time Frame: within the first 24 hours after surgery ]
- oxygen-saturation, respiratory rate, neurological status, need for administration of naloxone and/or active airway management [ Time Frame: within first 24 hours after surgery ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00544947
|Princess Royal Maternity Hospital|
|Glasgow, United Kingdom, G4 0SF|
|Principal Investigator:||Stephan Dalchow, FRCA||National Health Service|